Reach the investors backing rounds like this
Backed by Vsquared Ventures, East X Ventures +4 more · verified emails and LinkedIn on Datapile
StandardX raises £10m to build isotope refinery for cancer care and fusion - Indian Pharma Post
StandardX is a UK-based deep-tech startup developing the world's first scalable isotope refinery. They aim to address critical supply shortages of isotopes used in cancer care and fusion energy. The company's accelerator-based technology will manufacture a broad portfolio of rare isotopes at commercial scale, replacing fragmented and aging production facilities.
StandardX raises £10m to build isotope refinery for cancer care and fusion Indian Pharma Post
| Sep 23, 2026 | Magic AI | $11.0M | — | United Kingdom |
| Sep 21, 2026 | Luminids | $1.5M | Pre-seed | United Kingdom |
| Sep 21, 2026 | Allica Bank | $155.0M | Series D | United Kingdom |
| Sep 21, 2026 | Airtel Money | $800.0M | IPO | United Kingdom |
You just read who funded StandardX. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.